Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JNJ-64264681 |
Trade Name | |
Synonyms | JNJ 64264681|JNJ64264681 |
Drug Descriptions |
JNJ-64264681 is a BTK inhibitor that blocks signaling through the BCR signaling pathway, potentially resulting in growth inhibition of tumor cells over expressing BTK (NCI Drug Dictionary). |
DrugClasses | BTK inhibitor 37 |
CAS Registry Number | NA |
NCIT ID | C179289 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
JNJ-64264681 | JNJ-64264681 | 0 | 1 |
JNJ-64264681 + JNJ-67856633 | JNJ-64264681 JNJ-67856633 | 0 | 1 |